Mannkind (MNKD) FCF Margin (2011 - 2026)

Mannkind (MNKD) reported FCF Margin of 6.25% for Q1 2026, up 231.0% year-over-year from 1.89% in Q1 2025, and up 9.8% quarter-over-quarter from 6.92% in Q4 2025.

Mannkind (MNKD) FCF Margin (2011 - 2026) Analysis & Trends

Mannkind (MNKD) has 13 years of FCF Margin data on file, last reported at 6.25% in Q1 2026.

  • FCF Margin for Q1 2026 came in at 6.25%, up 231.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 5.19% (down 190.0% YoY), and the FY2025 annual result was 5.05%, down 644.0% from the prior year.
  • FCF Margin rose to 6.25% in Q1 2026 per MNKD's latest filing, from 6.92% in the prior quarter.
  • Over five years, FCF Margin peaked at 61.17% in Q3 2023 and troughed at 9716.0% in Q2 2022.
  • A 5-year average of 582.27% and a median of 3.16% in 2023 frame the typical range for FCF Margin.
  • The sharpest annual moves came in 2022 and 2023: FCF Margin plunged 962298 bps in 2022, then jumped 967456 bps in 2023.
  • A 5-year view of FCF Margin shows it stood at 23.66% in 2022, then jumped by 262 bps to 38.44% in 2023, then plunged by 51 bps to 18.8% in 2024, then sank by 137 bps to 6.92% in 2025, then advanced by 10 bps to 6.25% in 2026.
  • Business Quant data shows MNKD's FCF Margin at 6.25% in Q1 2026, 6.92% in Q4 2025, and 29.54% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - -
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn -3.98%
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 43.35%
9 Abivax 90.15 Bn 90.15 Bn - -
10 Mannkind 1.13 Bn 995.19 Mn 82.66 Mn -6.25%

Historic Data

Download Data
DateValue
Mar 31, 2026 -6.25%
Dec 31, 2025 -6.92%
Sep 30, 2025 29.54%
Jun 30, 2025 10.24%
Mar 31, 2025 -8.56%
Dec 31, 2024 18.80%
Sep 30, 2024 18.87%
Jun 30, 2024 0.17%
Mar 31, 2024 7.60%
Dec 31, 2023 38.44%
Sep 30, 2023 61.17%
Jun 30, 2023 -41.44%
Mar 31, 2023 -3.16%
Dec 31, 2022 -23.66%
Sep 30, 2022 -83.12%
Jun 30, 2022 -9,716.00%
Mar 31, 2022 -194.33%
Dec 31, 2021 -58.61%
Sep 30, 2021 -91.29%
Jun 30, 2021 -93.02%